Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD.
Saved in:
| Title: | Rivaroxaban Plus Aspirin Versus Aspirin Alone After Endovascular Revascularization for Symptomatic PAD: Insights From VOYAGER PAD. |
|---|---|
| Authors: | Rymer J; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.)., Anand SS; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Canada (S.S.A.)., Sebastian Debus E; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.)., Haskell LP; Janssen Research and Development, Raritan, NJ (L.P.H.)., Hess CN; Colorado Prevention Center Clinical Research, Aurora (C.N.H.).; Division of Cardiology (C.N.H.), Department of Medicine, University of Colorado School of Medicine, Aurora., Jones WS; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.)., Muehlhofer E; Bayer AG, Research & Development, Wuppertal, Germany (E.M.)., Berkowitz SD; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.).; Divisions of Cardiology and Hematology (S.D.B.), Department of Medicine, University of Colorado School of Medicine, Aurora., Bauersachs RM; CCB-Cardioangiologic Center Bethanien, Frankfurt and Center of Thrombosis and Hemostasis, University of Mainz, Germany (R.M.B.)., Bonaca MP; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University Heart & Vascular Center, University of Hamburg-Eppendorf, Hamburg, Germany (E.S.D., S.D.B., M.P.B.)., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC (J.R., W.S.J., M.R.P.). |
| Source: | Circulation [Circulation] 2023 Dec 12; Vol. 148 (24), pp. 1919-1928. Date of Electronic Publication: 2023 Oct 18. |
| Publication Type: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
